
Harpe Bioherbicide Solutions Licenses CRISPR-Cas9 Technology from Corteva Bioscience and the Broad Institute of MIT/Harvard to Develop New Crop Systems Tolerant to Harpe Bioherbicides
Harpe Bioherbicide Solutions, an agricultural technology company specializing in natural and sustainable herbicide solutions, has entered into an intellectual property licensing agreement with Corteva Agriscience and the Broad Institute of MIT and Harvard. The agreement involves the use of foundational CRISPR-Cas9 and related gene editing tools to research and develop crop systems tolerant to Harpe Bioherbicides.
Harpe Bioherbicide Solutions is focused on creating natural, non-selective herbicide formulations derived from plant extracts. The collaboration with CRISPR-Cas9 technology aims to demonstrate the feasibility of developing crops that can withstand applications of Harpe Bioherbicides. This will address the need for enhanced and differentiated weed control solutions for farmers and expand the commercial potential of this technology.
Harpe Bioherbicide Solutions’ products, which employ new sites and modes of action, have the potential to lead the bioherbicide market with innovative products. They can serve as both pre-emergent weed prevention and post-emergent weed control, either independently or in conjunction with synthetic chemical herbicides. This approach minimizes soil and environmental damage while increasing crop yields safely.
The use of CRISPR-Cas9 technology is expected to contribute to more sustainable herbicide practices in the agricultural industry, helping to combat weed resistance challenges and promote sustainable global food production.
Harpe Bioherbicide Solutions is collaborating with Solis Agrosciences, based in St. Louis, to expedite the development of herbicide-tolerant crop systems using Harpe’s technology. Solis Agrosciences offers research and development services and a comprehensive pipeline for designing, generating, and testing transgenic and gene-edited plants efficiently and cost-effectively.